💨 Abstract
Alaunos Therapeutics, Inc. (TCRT) reported a loss of $1.1 million for the second quarter, amounting to a 63 cents per-share loss. This information was generated by Automated Insights using data from Zacks Investment Research. Accessing detailed reports is possible through the provided links.
Courtesy: WTOP Staff
Suggested
‘These are human beings’: Religious leaders criticize President Trump’s grim portrayal of DC -
Oramed: Q2 Earnings Snapshot -
Carbon Streaming: Q2 Earnings Snapshot -
Barbadillo, la prisión sin barrotes para expresidentes que se ha convertido en símbolo de la crisis política en Perú -
How Rattler and Shough handled live pass rush will be another data point in Saints’ QB competition -
Md. gov. calls Trump a ‘chicken hawk’ in use of National Guard, while Va. gov. says it will make DC safer -
Woman pleads guilty to assault for spitting on top DC prosecutor during interview -
Is the extra law enforcement presence in DC working? -
Plus: Q2 Earnings Snapshot -